Mantle Cell Lymphoma (MCL) Completed Phase 1 / 2 Trials for Bortezomib (DB00188)

Also known as: Lymphoma, Mantle-Cell / Mantle Cell Lymphoma / Mantle-Cell Lymphoma / Lymphoma, Mantle- Cell / Lymphoma, Mantle Cell / Mantle-Cell Lymphomas / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphomas

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00407303Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)Treatment
NCT00571493VELCADEĀ®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell LymphomaTreatment
NCT00633594Rituximab, Lenalidomide, and Bortezomib in Mantle Cell LymphomaTreatment